Custom perfume development is not one creative act; it is a sequence of approvals, and each approval narrows what can still change without cost. Brands that understand the sequence decide faster and avoid the expensive habit of reopening a choice after the formula is fixed. What follows is the order in which a scent usually becomes a product, and what the brand is genuinely signing off at each step.
Key takeaways
- Custom development moves through a written brief, direction sampling, refinement, application testing, stability and compliance checks, and finally bulk approval.
- The brief is the highest-leverage document in the project because it fixes category, market, price ceiling and the wear experience the product should deliver.
- Sampling narrows creative options, and rejecting a direction in the first round costs far less than revisiting it once the formula is locked.
- A scent that performs well on a blotter can behave differently in the carrier, base and package it will actually ship in, so application testing belongs before approval.
- Every approval should be made against a labelled reference sample, because memory is a poor judge of a smell across several weeks.
First-time founders often picture development as a creative conversation that ends with a scent they love. In practice it is a chain of decisions, and the quality of the finished product depends on how clearly each one is made.
The stages below are not a bureaucratic ritual. Each exists because something went wrong often enough that the industry built a checkpoint around it. Knowing why each checkpoint exists makes it easier to move through them quickly.
The brief decides more than the first sample
A brief is not a mood board. It is a short technical document that tells a perfumer what the product must do, and it is the single document that most reliably predicts whether development runs smoothly.
Brands that write a precise brief usually receive directions that are closer to the target on the first attempt. Brands that send references without constraints often receive beautiful samples that cannot be produced at the target cost.
What the brief has to contain
Four things: the product category and where it will be used, the market it will be sold in, the target unit cost or cost ceiling, and a plain description of the wear experience you want, including when the scent should be noticeable and how long it should last. References help, but they should illustrate the description rather than replace it.
Why the market belongs in the brief
Climate changes how a formula reads on skin, and regulation changes what may go into it. A brief that names the selling markets lets the lab anticipate both, instead of discovering a labelling or restriction issue after the scent is approved.
Technical coverage of formulation work consistently treats performance testing in the intended application as part of development rather than a final formality [1]. The same logic applies to the market: it is an input to the formula, not a detail to settle later.
Who approves, and when
Decide before sampling begins who inside the brand has the final vote, and whether marketing, product development or a founder holds it. Development slows dramatically when three people each hold a veto and no one holds a decision.
The development sequence in order
- Written brief and reference setCategory, market, cost ceiling, wear description and a small number of reference scents that illustrate the direction.
- First direction roundThe lab returns several interpretations of the brief. Judge them as directions, not as finished products, and narrow to one or two.
- RefinementThe chosen direction is adjusted in steps: opening, heart, dry-down, sweetness, texture. Each round should carry one clear instruction.
- Application testingThe formula is evaluated in the base and format it will ship in, because a carrier changes how a scent lifts and how long it stays.
- Stability and compliance reviewThe near-final formula is checked for how it behaves over time and against the restrictions that apply in the target markets.
- Bulk approval against a referenceThe first production batch is compared with the approved reference sample before filling continues, not after the goods are packed.
What the brand receives at each stage
| Stage | What the brand receives | Decision to make | Warning sign |
|---|---|---|---|
| Brief | A written interpretation and a costed direction | Confirm category, market, ceiling and wear target | Nobody has asked about the target unit cost |
| Direction sampling | A small set of candidate scents with descriptions | Choose a direction, not a final formula | Every sample is presented as perfect |
| Refinement | Revised versions tied to your written comments | Approve one version as the reference | The same comment returns across three rounds |
| Application testing | Performance notes in the real base and format | Confirm the scent still works in use | Testing happened on paper only |
| Bulk production | A production sample and documentation | Compare batch against the reference sample | No approved reference is kept on file |
The warning-sign column is the one worth copying into your own notes. Almost every delay in custom development is visible one stage earlier as a small unanswered question.
Approving a scent you cannot photograph
A scent cannot be reviewed in a file. It has to be smelled, on skin, at more than one moment, and against something. That makes the approval process unusual, and it rewards a little discipline.
Keep a labelled reference set
Store the approved sample with a date, a code and the formula version it corresponds to. Every later comparison should be made against that bottle rather than against memory, because noses adapt within minutes and opinions drift within weeks.
Evaluators across the industry rely on shared odor description references to keep vocabulary consistent between people and sites [2], and a brand can borrow the same idea in miniature by writing one sentence about each reference sample.
Judge the product, not the meeting
Smell the sample on skin at the start of a session, then again after a few hours, ideally on more than one person. Impressions formed in a conference room favour bright openings and underrate the dry-down that customers will actually live with.
The practical test of fit with a supplier is simple: ask a custom fragrance development partner to describe how a recent brief moved from first direction to bulk production, and listen for how often the brief itself had to be reopened.
The most common cause of a disappointing custom project is not a bad perfumer; it is a brief that kept changing after sampling had begun. Every new constraint introduced late, whether a lower cost target, a different market or a new packaging format, invalidates work that has already been done. If something must change, change it deliberately and accept the reset. Manufacturers such as Xuelei in Guangzhou keep sampling and filling under one roof, which means the same team sees a formula from first direction through to bulk, and that continuity makes late changes more visible and easier to price.
Sources
- Cosmetics & Toiletries —— A technical magazine for cosmetic formulators, covering ingredients, formulation science and testing methods.
- The Good Scents Company —— A reference database of aroma materials with odour descriptions, CAS numbers and typical usage information.
Frequently asked questions
How long does custom perfume development take?
It depends on how fast the brand makes decisions and how many rounds the direction needs. The sequence itself is fixed: brief, direction sampling, refinement, application testing, stability and compliance review, then bulk approval. Most delay comes from waiting on feedback or from reopening a decision that was already closed.
How many samples should a brand expect before approving?
There is no fixed count, because it depends on how specific the brief was. A tight brief usually converges in fewer rounds. What matters more than the number is that each round carries one clear instruction, so the next sample tests a single change rather than several at once.
Can I skip application testing if I love the blotter sample?
It is risky. A blotter shows the opening and the mid-section clearly, but it cannot show how the scent behaves in a body lotion, a shampoo base or an alcohol carrier, or how it interacts with packaging. Testing in the real format before approval is cheaper than discovering the difference in bulk.
Who owns the formula after development?
That has to be agreed in writing before work starts, and the answer varies by supplier and by whether the formula was developed exclusively for you. Ask whether the formula may be sold to another brand, and whether you receive documentation that lets a different manufacturer reproduce it.
What happens if the bulk batch smells different from the sample?
The approved reference sample is the standard, so the first production batch should be compared against it before filling continues. Small differences can come from resting time, carrier ratios or raw material lots. If the difference is clear, the batch should be held and reviewed rather than shipped and explained.